Global High-Flow Nasal Cannula Market Is Anticipated To Register A Staggering CAGR Of 11.8% By 2025

download 2022 09 02T141016.375

The latest research report published by Fact.MR on the Survey of High-flow Nasal Cannula Market is intended to offer reliable data on various key factors shaping the growth curve & outlook of High-flow Nasal Cannula market. This report works as a rich source of information for key entities such as policy makers, end-use industries, investors, and opinion leaders.

The Demand analysis of High-flow Nasal Cannula Market offers a comprehensive analysis of diverse features, demand, product developments, revenue generation, and sales of High-flow Nasal Cannula Market across the globe.

Click Here To get a Sample Report (Including Full TOC, Table & Figures):-

Key Takeaways of Global High-flow Nasal Cannula Market Study:

  • Active Humidifiers are anticipated to account for a major chunk of the global high-flow nasal cannula market (>1/4th). Growing focus on the efficiency of humidified oxygen supply in high-flow nasal cannula therapy shall drive innovations in the components segment. This is anticipated to leverage the market.
  • By application, active respiratory failure shall leverage the high-flow nasal cannula market. The specific advantages offered by the high-flow nasal cannula market coupled with growing acceptance among patients are key growth drivers. The segment is poised to hold three-tenth of the high-flow nasal cannula market.
  • The Sleep Apnea segment is the second-most lucrative in the global high-flow nasal cannula market. The segment shall grow impressively at a CAGR of 13.5% during the forecast period.
  • By region, North America shall dominate the global high-flow nasal cannula market. Adoption of Non-invasive ventilation (NIV) and continuous positive airway pressure (CPAP) procedures is anticipated to augment the high-flow nasal cannula market. The region shall capture more than two-fifth of the overall market.
  • Asia-Pacific shows lucrative growth opportunity. It is anticipated to expand at a CAGR of 13.2%, capturing more than one-fifth of the market. Rising population and the consequent prevalence of respiratory disorders is projected to boost the Asia-Pacific high-flow nasal cannula market.

“The global high-flow nasal cannula market demonstrates lucrative growth prospects. The increasing prevalence of respiratory disorders has prompted major manufacturers to invest in technological advancements to cater to the burgeoning demand,” concludes a Fact.MR analyst.

High-flow Nasal Cannula Market Segmentation

Fact.MR has studied the high-flow nasal cannula market with detailed segmentation on the basis of component, application, end-user and key regions.

  • By Component :

    • Air/Oxygen Blend
    • Air Humidifier
    • Single Heated Tube
    • Nasal Cannula
    • Other Consumables
  • By Application :

    • Acute Respiratory Failure
    • Chronic Obstructive Pulmonary Disease (COPD)
    • Carbon Monoxide Toxicity
    • Bronchiectasis
    • Sleep Apnea
    • Other Applications
  • By End-user :

    • Hospitals
    • Long-term Care Centers
    • Ambulatory Care Centers
    • Tomosynthesis
    • Other End-users
  • Key Regions :

    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa

Technological Enhancement to Remain Key Premise for Market Expansion:

The global high-flow nasal cannula market is fragmented. The key companies are Fisher & Paykel Healthcare Limited, BD/CareFusion, ResMed Inc., and Telefax incorporated. These players consistently innovate their product portfolios by virtue of technological advancements to acquire market presence.

Fisher & Paykel is a leading player in the global high-flow nasal cannula market. Its flagship products include F&P 950 Humidifier, Optiflow High-flow System and the AIRVO 2. Other products include OptiFlowTM Nasal High, F&P Brevida Masks and the F&P SimplusTM Full Face Masks.

ResMed, Inc. is another market leader in the respiratory therapy market. It offers a strong product portfolio for the treatment of sleep apnea and non-invasive ventilation. Its flagship products include AirView, myAir and ClimateLine MAX for the treatment and management of sleep apnea and respiratory disorders.